Companies Transforming Pharmacovigilance with Veeva Safety

Enabling Collaborative Pharmacovigilance

Pharmacovigilance success depends on collaboration and technologies that are aligned with
current business models and growing safety demands.

Camurus
Camurus Increases Efficiency with Unified Safety Solution

Merck, CRISPR Therapeutics, and Biotech
Veeva Safety is Enabling Biotechs to Work More Effectively

OM Pharma
Simplifying Pharmacovigilance Processes with Veeva Safety

Merck
Streamlining Processes with Unified and Connected Safety

UCB
Safety Transformation Journey

CRISPR Therapeutics
Bringing Safety In-house for Real-time Data Access and Visibility

Improving Oversight and Case Processing Efficiency when Working with CROs and Service Providers

Biotechs and CROs are collaborating on the same safety solution and have real-time data access for faster and better decision-making.

Camurus
Reduces Case Processing Time and Costs with In-House Safety

Dermavant
Managing Pharmacovigilance Oversight with Veeva Safety

Inhibrx
Direct Oversight and Control While Gaining CRO Flexibility

Biomapas
Pharmacoviglance Outsourcing

Getting a Validated and Future Proof Pharmacovigilance Solution

Implementing and validating Veeva Safety.

Cancer Research UK
Drives Efficiencies with Veeva Safety

Camurus

“Using Veeva Safety, we have reduced case processing time by at least 30 minutes per case while maintaining compliance.”

Johanna Strandell

Director Patient Safety, QPPV, Camurus

CRISPR Therapeutics

“Veeva Safety beats a lot of the competition by a long shot. It’s intuitive and easy to use, and having first-hand access to our safety data is irreplaceable.”

Hanssar Chacon

Sr. Director, Global PV and Risk Management

Biomapas

“Keeping up with increasing requirements across regions is the biggest challenge for pharmacovigilance providers. We were looking for a safety solution with a flexible model that would grow with us.”

Martijn van de Leur

Head of Global Pharmacovigilance